China Pharma Distributors Expand While Retail Pharmacies Face Strong Headwinds
This article was originally published in PharmAsia News
Executive Summary
An annual report from China’s Ministry of Commerce describes a faster pace of consolidation in the distribution sector, but prolonged challenges for retailers.
You may also be interested in...
Pfizer Teams With Distributor Jointown To Delve Deeper Into China's Rural Markets
SHANGHAI - Pfizer Inc., like many of its Big Pharma peers is seeking out local Chinese partners to gain access to China's lower-tier cities and rural areas. To that end, the world's largest pharma company recently signed an agreement with China's third-largest pharma distributor Jointown Pharmaceutical Group Co., Ltd. to distribute Pfizer products in markets outside of big cities
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.